News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
SCOPIA CAPITAL MANAGEMENT LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.7% stake in Retrophin, Inc. |
| 01/10/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 2.1% stake in Zogenix Inc. |
| 01/10/2020 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 1.4% stake in Horizon Pharma Public Limited Company |
| 11/12/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Acorda Therapeutics, Inc. |
| 08/12/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.9% stake in Retrophin, Inc. |
| 04/10/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 1.8% stake in La Jolla Pharmaceutical Company |
| 03/11/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.7% stake in Prothena Corporation Public Limited Company |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.5% stake in Spirit AeroSystems Holdings, Inc. |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 6.4% stake in Horizon Pharma Public Limited Company |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.8% stake in Acorda Therapeutics, Inc. |
| 01/10/2019 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 7.1% stake in Zogenix Inc. |
| 12/10/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.4% stake in Entercom Communications Corp. |
| 10/10/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/10/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 12.7% stake in Zogenix Inc. |
| 07/10/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 4.9% stake in PTC Therapeutics, Inc. |
| 06/11/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 6.8% stake in GW Pharmaceuticals PLC |
| 04/10/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 12.9% stake in PTC Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 5% stake in Spirit AeroSystems Holdings, Inc. |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.9% stake in Horizon Pharma Public Limited Company |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in United Therapeutics Corporation |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 16.9% stake in Retrophin, Inc. |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Novelion Therapeutics Inc. |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 9.6% stake in Entercom Communications Corp. |
| 02/14/2018 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 12.2% stake in GW Pharmaceuticals PLC |
| 09/11/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/11/2017 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0.8% stake in NeuroDerm Ltd. |
| 03/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/14/2017 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Fluidigm Corporation |
| 02/14/2017 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Express, Inc. |
| 02/14/2017 |
SC 13G/A
| SCOPIA CAPITAL MANAGEMENT LP reports a 0% stake in Beneficial Bancorp, Inc. |
|
|
|